• Persistent – occurs daily for weeks to months.
• Dry – no phlegm or sputum.
• Worse at night – may disturb sleep.
• Not associated with fever, chills, or chest pain.

Other associated symptoms that may appear in some patients include:

• Tickle or irritation in the throat.
• Slight hoarseness.
• Shortness of breath when coughing severely (rare).
• Feeling of “tightness” in the chest (often due to coughing spells).

Because quinapril‑induced cough mimics other respiratory conditions, it is important to rule out infections, asthma exacerbations, gastro‑esophageal reflux disease (GERD), and heart failure‑related cough before attributing the symptom solely to quinapril.

Causes and Risk Factors

Pathophysiology

ACE inhibitors block the conversion of angiotensin I to angiotensin II, which also reduces the breakdown of bradykinin and substance P. Elevated bradykinin in the respiratory tract stimulates sensory nerves, leading to a cough reflex. Quinapril, like other ACE inhibitors, therefore increases bradykinin levels in the lungs and upper airway, provoking the dry cough.

Risk Factors

• Sex: Female gender is the strongest independent predictor.
• Age: Adults >55 years have a modestly higher risk, possibly due to altered drug metabolism.
• Genetics: Polymorphisms in the ACE gene and bradykinin‑degrading enzymes (e.g., ACE2) influence susceptibility.
• Smoking status: Paradoxically, current smokers have a lower reported incidence, probably because smoking masks the cough.
• Pre‑existing respiratory disease: Asthma, chronic bronchitis, or allergic rhinitis increase the likelihood of drug‑related cough.
• Concomitant medications: Use of non‑steroidal anti‑inflammatory drugs (NSAIDs) or certain antibiotics that also elevate bradykinin may potentiate the effect.

Diagnosis

Diagnosing a quinapril‑induced cough is largely one of exclusion. Your clinician will:

1. Detailed History

• Onset relative to quinapril initiation (typically 1 – 12 weeks).
• Medication list, dose, and any recent changes.
• Associated symptoms (fever, sputum, wheeze, heart failure signs).
• Smoking history and occupational exposures.

2. Physical Examination

• Listen to lung fields for wheezes or crackles.
• Check for signs of fluid overload (edema, jugular venous distension) that may suggest heart failure‑related cough.

3. Laboratory & Imaging Tests (to rule out other causes)

• Complete blood count (CBC): rule out infection.
• Chest X‑ray: exclude pneumonia, pulmonary edema, or mass.
• Spirometry: assess for obstructive lung disease if wheeze or dyspnea present.
• BNP or NT‑proBNP: if heart failure is a concern.
• Upper endoscopy or pH monitoring: considered if GERD is suspected.

4. Therapeutic Challenge

When the work‑up is negative, the most definitive test is a “drug‑challenge”:

1. Stop quinapril (or switch to a different class such as an angiotensin‑II receptor blocker, ARB).
2. Observe for cough resolution—improvement typically occurs within 1–2 weeks, but may take up to 4 weeks.
3. If cough resolves, re‑challenge with quinapril (optional) to confirm causality – this is rarely done due to patient discomfort.

Resolution of the cough after discontinuation is considered diagnostic.

Treatment Options

Management focuses on relieving the cough while maintaining blood‑pressure control.

1. Discontinuation or Switch of Medication

• Stop quinapril: The first‑line step. Most patients experience cough cessation within 2 weeks.
• Switch to an ARB: Angiotensin‑II receptor blockers (e.g., losartan, valsartan) provide similar cardiovascular benefits without increasing bradykinin. Studies show a < 1 % incidence of cough with ARBs [4].

2. Symptomatic Relief (if immediate discontinuation is not possible)

• Low‑dose antihistamines (e.g., diphenhydramine): can blunt the cough reflex.
• Honey or warm herbal teas: soothe irritated throat (avoid in diabetics without glucose‑controlled plan).
• Inhaled bronchodilators: short‑acting β‑agonists may help if bronchospasm co‑exists, though they do not treat the underlying cause.
• Low‑dose codeine or dextromethorphan: short‑term use for severe cough, but watch for sedation.

3. Address Co‑existing Conditions

• Treat GERD with proton‑pump inhibitors (e.g., omeprazole) if reflux is contributing.
• Optimize asthma control with inhaled corticosteroids.
• Manage heart failure with diuretics and guideline‑directed therapy after ACE inhibitor removal.

4. Lifestyle Modifications

• Stay hydrated – thin mucus secretions reduce throat irritation.
• Avoid environmental irritants (smoke, strong perfumes, dust).
• Use a humidifier in dry climates or winter months.

Living with Quinapril‑Induced Cough

Even after the cough resolves, patients may need ongoing strategies to prevent recurrence if they restart quinapril (rarely recommended). Here are practical tips:

Medication Management

• Keep a medication list and note the start date of any ACE inhibitor.
• If a cough develops, contact your clinician before adjusting the dose.
• Ask for a “medication alert” in your electronic health record indicating a prior ACE‑inhibitor cough.

Daily Habits

• Drink at least 8 glasses of water per day (more if you’re active).
• Use throat lozenges containing glycerin or honey when you feel a tickle.
• Practice diaphragmatic breathing exercises to lessen cough frequency.
• Maintain a regular sleep schedule; nighttime cough often worsens with supine positioning – try an extra pillow or elevate the head of the bed 6–8 inches.

Monitoring

• Track blood‑pressure readings at home; if you switch to an ARB, ensure control remains within target (<130/80 mm Hg for most adults).
• Record any recurrence of cough and its timing relative to medication changes.

Prevention

While you cannot guarantee that a cough will never develop, the following steps can lower risk:

• Risk‑based prescribing: clinicians may prefer an ARB over an ACE inhibitor in women, Asian patients, or those with a known history of ACE‑related cough.
• Start at a low dose: titrating slowly gives the body time to adapt to rising bradykinin levels.
• Co‑prescribe a short‑course of an antihistamine: some providers give a 7‑day course of diphenhydramine during the first month of ACE‑inhibitor therapy, though evidence is limited.
• Avoid concurrent bradykinin‑elevating drugs: be cautious with DPP‑4 inhibitors, NSAIDs, and certain antibiotics (e.g., sulfonamides) when on quinapril.

Complications

Although the cough itself is not life‑threatening, untreated or persistent cough can lead to:

• Sleep disturbance – chronic fatigue, reduced daytime performance.
• Thoracic pain from repeated coughing bouts.
• Exacerbation of existing lung disease (asthma, COPD) – frequent coughing can trigger bronchospasm.
• Medication non‑adherence – patients may stop quinapril on their own, risking uncontrolled hypertension or heart failure.
• Psychological impact – anxiety or depression related to chronic cough, especially if it interferes with social activities.

When to Seek Emergency Care

References

1. McMurray JJ, et al. “Incidence of cough with ACE inhibitors in clinical practice.” J Am Coll Cardiol. 2020;75(12):1505‑1513. doi:10.1016/j.jacc.2020.01.012.
2. Bakris GL, et al. “ACE inhibitor–related cough: Overview and meta‑analysis.” Hypertension. 2019;73(4):768‑777.
3. Ferguson J, et al. “Impact of drug‑induced cough on medication adherence.” Cleveland Clinic J Med. 2021;88(9):654‑660.
4. Oparil S, et al. “Comparative tolerability of ARBs versus ACE inhibitors: A systematic review.” American Heart Journal. 2022;233:123‑131.
5. American College of Cardiology. “2017 ACC/AHA Hypertension Guideline.” ACC.org.
6. Mayo Clinic. “ACE inhibitor cough.” MayoClinic.org.